📣 VC round data is live. Check it out!

Capital Point Valuation Multiples

Discover revenue and EBITDA valuation multiples for Capital Point and similar public comparables like Fund Creation Group Co, Mountain Alliance, Azevedo & Travassos Energia, Renewable Ventures Nordic and more.

Capital Point Overview

About Capital Point

Capital Point Ltd is a holding company. The Company focuses its investments in technology based early stage companies in biotechnological and medical industry.


Founded

2000

HQ

Israel

Employees

N/A

Sectors

Financials (FY)

Revenue: $628K
EBITDA: $5M

EV

$8M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Capital Point Financials

Capital Point reported last fiscal year revenue of $628K and EBITDA of $5M.

In the same fiscal year, Capital Point generated ($1M) in gross profit, $5M in EBITDA, and $3M in net income.


Capital Point P&L

In the most recent fiscal year, Capital Point reported revenue of $628K and EBITDA of $5M.

Capital Point is profitable as of last fiscal year, with gross margin of (209%), EBITDA margin of 821%, and net margin of 400%.

See analyst estimates for Capital Point
Last FY202320242025202620272028
Revenue$628K$83K$334K$628K
Gross Profit($1M)($2M)($2M)($1M)
Gross Margin(209%)(2248%)(476%)(209%)
EBITDA$5M$7M$5M$5M
EBITDA Margin821%8438%1588%821%
EBIT Margin795%8217%1532%795%
Net Profit$3M$590K($8M)$3M
Net Margin400%707%(2467%)400%

Financial data powered by Morningstar, Inc.

Capital Point Stock Performance

Capital Point has current market cap of $22M, and enterprise value of $8M.


Capital Point's stock price is $0.16.

Capital Point has an EPS (earnings per share) of $0.02.

See more trading valuation data for Capital Point
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$8M$22M0.0%$0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Capital Point Valuation Multiples

Capital Point trades at 13.2x EV/Revenue multiple, and 1.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Capital Point

Capital Point Financial Valuation Multiples

As of May 10, 2026, Capital Point has market cap of $22M and EV of $8M.

Capital Point has a P/E ratio of 8.7x.

Last FY202320242025202620272028
EV/Revenue13.2x99.5x24.9x13.2x
EV/EBITDA1.6x1.2x1.6x1.6x
EV/EBIT1.7x1.2x1.6x1.7x
EV/Gross Profit(6.3x)(4.4x)(5.2x)(6.3x)
P/E8.7x36.8x(2.6x)8.7x
EV/FCF(3.8x)(3.8x)(3.6x)(3.8x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Capital Point Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Capital Point Margins & Growth Rates

In the most recent fiscal year, Capital Point reported gross margin of (209%), EBITDA margin of 821%, and net margin of 400%.

See estimated margins and future growth rates for Capital Point

Capital Point Margins

Last FY20242025202720282029
Gross Margin(209%)(476%)(209%)
EBITDA Margin821%1588%821%
EBIT Margin795%1532%795%
Net Margin400%(2467%)400%
FCF Margin(344%)(693%)(344%)

Capital Point Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth300%88%
Gross Profit Growth(15%)(17%)
EBITDA Growth(25%)(3%)
EBIT Growth(25%)(2%)
Net Profit Growth(1497%)(130%)
FCF Growth7%(7%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Capital Point Operational KPIs

Access forward-looking KPIs for Capital Point
Last FY202320242025202620272028
G&A Expenses to Revenue93%714%192%93%
Opex to Revenue(1004%)(10466%)(2008%)(1004%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Capital Point Competitors

Capital Point competitors include Fund Creation Group Co, Mountain Alliance, Azevedo & Travassos Energia, Renewable Ventures Nordic, Regent Pacific Group, Private Assets SE, Zest, G2D Investments, Bulgarian Private Equity and FISCO.

Most Capital Point public comparables operate across PE & VC.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Fund Creation Group Co0.7x7.1x
Mountain Alliance119.3x(14.8x)
Azevedo & Travassos Energia34.6x(23.6x)
Renewable Ventures Nordic
Regent Pacific Group85.4x(7.1x)
Private Assets SE0.2x32.6x
Zest6.5x7.5x
G2D Investments(44.7x)(2.2x)

This data is available for Pro users. Sign up to see all Capital Point competitors and their valuation data.

Start Free Trial

Capital Point Investment Activity

Capital Point has invested in 5 companies to date.

Latest investment by Capital Point was on February 28th 2022. Capital Point invested in Visionary.ai in their $3M Seed round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Capital Point

Visionary.ai
Fourier Optics
Intuition Robotics
RDD Pharma
Description
Visionary.ai is a computer vision company enhancing imaging in adverse conditions. Tel Aviv-headquartered and founded in 2019, it deploys AI algorithms to improve low-light, fog, and high-dynamic-range photography in smartphones and dashcams. Its tech powers Samsung Galaxy cameras and automotive ADAS from Mobileye. Visionary.ai's models boost signal-to-noise ratios by 40 percent, with deployments in 50 million devices by 2024.
Fourier Optics is a startup crafting metasurface optics for AR glasses. Its flat lenses achieve 50-degree fields of view without bulk, diffracting light for see-through displays. Tested in prototypes with waveguide combiners, the optics target consumer headsets from Asian manufacturers.
Intuition Robotics is a Tel Aviv-headquartered developer of ElliQ, an AI companion robot for older adults promoting activity and independence. Backed by U.S. patents in AI, human-robot interaction, and design, the company creates proactive agents for sustained user engagement in senior care settings worldwide.
RDD Pharma is a developer of therapeutics for anorectal and lower gastrointestinal disorders. Based in the United States, the company engineers targeted drug delivery systems addressing anatomical challenges, with formulations for conditions like hemorrhoids and fissures.
HQ CountryIsraelIsraelIsraelIsrael
HQ City
Tel Aviv
Ramat Gan
Ramat Gan
Ofakim
Deal Date28 Feb 20221 Jan 202213 Feb 202016 Nov 2017
RoundSeedSeedSeries BSeries B
Raised$3M$2M$36M$10M
InvestorsCapital Point; Ibex Investors; Spring VenturesAriel Maislos; Capital Point; Ehud Weinstein; Eri Steimatzky; Gilad Engel; Ofir ShalviBloomberg Beta; Capital Point; Happiness Capital; iRobot; OurCrowd; Samsung NEXT; Sompo Holdings; SparX Group; Toyota Ventures; Union Tech VenturesCapital Point; OrbiMed; Pharmascience
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Capital Point investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Capital Point

When was Capital Point founded?Capital Point was founded in 2000.
Where is Capital Point headquartered?Capital Point is headquartered in Israel.
Is Capital Point publicly listed?Yes, Capital Point is a public company listed on Tel Aviv Stock Exchange.
What is the stock symbol of Capital Point?Capital Point trades under CPTP ticker.
When did Capital Point go public?Capital Point went public in 2006.
Who are competitors of Capital Point?Capital Point main competitors include Fund Creation Group Co, Mountain Alliance, Azevedo & Travassos Energia, Renewable Ventures Nordic, Regent Pacific Group, Private Assets SE, Zest, G2D Investments, Bulgarian Private Equity, FISCO.
What is the current market cap of Capital Point?Capital Point's current market cap is $22M.
What is the current revenue of Capital Point?Capital Point's last fiscal year revenue is $628K.
What is the current EV/Revenue multiple of Capital Point?Current revenue multiple of Capital Point is 13.2x.
Is Capital Point profitable?No, Capital Point is not profitable.
How many companies Capital Point has acquired to date?Capital Point hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Capital Point has invested to date?As of May 2026, Capital Point has invested in 5 companies.
What was the last Capital Point investment?On 28th February 2022 Capital Point invested in Visionary.ai, participating in a $3M Seed round, alongside Ibex Investors and Spring Ventures.
In what companies Capital Point invested in?Capital Point invested in Intuition Robotics, RDD Pharma, Visionary.ai, Fourier Optics, and righTune.

See public comps similar to Capital Point

Lists including Capital Point

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial